ADMA Biologics, Inc

(NASDAQ:ADMA)

Latest On ADMA Biologics, Inc (ADMA):

Date/Time Type Description Signal Details
2023-05-11 01:31 ESTNewsADMA Biologics GAAP EPS of -$0.03 beats by $0.01, revenue of $57M beats by $3.59MN/A
2023-05-11 01:30 ESTNewsADMA Biologics, Inc. (ADMA) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 23:31 ESTNewsADMA Biologics Q1 2023 Earnings PreviewN/A
2023-03-30 00:16 ESTNewsADMA Biologics: Growth Trends Pointing To ProfitabilityN/A
2023-03-24 06:16 ESTNewsADMA Biologics GAAP EPS of -$0.06 beats by $0.01, revenue of $49.95M beats by $1.88MN/A
2023-03-24 06:16 ESTNewsADMA Biologics expects first-time positive EBITDA by second half of yearN/A
2023-03-24 06:15 ESTNewsADMA Biologics, Inc. (ADMA) Q4 2022 Earnings Call TranscriptN/A
2023-03-22 23:00 ESTNewsADMA Biologics Q4 2022 Earnings PreviewN/A
2023-02-08 18:02 ESTNewsADMA Biocenters receives FDA approval for eighth plasma collection centerN/A
2023-01-17 17:02 ESTNewsADMA Biologics gains as guidance exceeds consensusN/A
2023-01-15 06:00 ESTNewsADMA Biologics: FY22 Numbers Key Inflection PointN/A
2022-12-13 19:01 ESTNewsAdma gets FDA approval for room temperature storage of Asceniv, BivigamN/A
2022-12-08 03:17 ESTNewsADMA Biologics stock dips after pricing ~$60M share offeringN/A
2022-12-07 07:16 ESTNewsADMA Biologics down 7% following stock offeringN/A
2022-11-11 05:31 ESTNewsADMA Biologics hits 52-week high after strong Q3 beatN/A
2022-11-09 19:31 ESTNewsADMA Biologics GAAP EPS of -$0.08 in-line, revenue of $41.09M beats by $6.61MN/A
2022-11-09 19:30 ESTNewsADMA Biologics, Inc. (ADMA) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 01:31 ESTNewsADMA Biologics Q3 2022 Earnings PreviewN/A
2022-10-31 13:46 ESTNewsAdma stock rises on FDA approval of North Carolina-based plasma collection centerN/A
2022-10-24 18:01 ESTNewsAdma Biologics: Understanding The Risks Of Blood Plasma CollectionN/A
2022-08-22 16:50 ESTNewsADMA Biologics: Strong Growth Is Clearing The Path To ProfitabilityN/A
2022-08-11 22:17 ESTNewsADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 22:16 ESTNewsAdma stock rises 10% after Q2 revenue nearly doubles, net loss narrowsN/A
2022-08-11 05:31 ESTNewsADMA Biologics GAAP EPS of -$0.07, revenue of $33.9MN/A
2022-08-11 05:30 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 17:45 ESTNewsADMA Biologics Q2 2022 Earnings PreviewN/A
2022-06-27 23:02 ESTNewsADMA's 6th plasma collection facility gets FDA approvalN/A
2022-06-21 22:02 ESTNewsADMA biologics to enter Russell 2000 indexN/A
2022-05-13 06:31 ESTNewsADMA Biologics: A Path To Profits Looks ClearN/A
2022-05-12 11:47 ESTNewsADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-11 18:00 ESTNewsADMA Biologics GAAP EPS of -$0.13 misses by $0.04, revenue of $29.1M beats by $0.95MN/A
2022-05-11 18:00 ESTNewsADMA Biologics up 4% after increasing 2022 revenue guidanceN/A
2022-05-10 22:45 ESTNewsADMA Biologics Q1 2022 Earnings PreviewN/A
2022-04-19 02:16 ESTNewsADMA: Pertinent UpdatesN/A
2022-04-04 13:21 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-29 21:17 ESTNewsADMA Biologics' 2021 Numbers Showed Continued Strong ExecutionN/A
2022-03-25 12:19 ESTNewsADMA Biologics GAAP EPS of -$0.09 beats by $0.01, revenue of $26.38M beats by $4.61MN/A
2022-03-25 12:19 ESTNewsADMA Biologics up in after-hours trading following quarterly top and bottom line beatsN/A
2022-03-25 12:18 ESTNewsADMA Biologics gets FDA approval to extend shelf life of Asceniv, BivigamN/A
2022-03-24 02:33 ESTNewsADMA Biologics Q4 2021 Earnings PreviewN/A
2022-02-10 22:16 ESTNewsAdma Biologics activist said to support strategic reviewN/A
2022-01-19 08:15 ESTNewsADMA biologics expects record preliminary 4Q and FY21 revenues to be above the consensusN/A
2022-01-18 16:46 ESTNewsADMA Biologics wins FDA nod for its fourth plasma collection centerN/A
2022-01-18 16:46 ESTNewsADMA Biologics: 2021 Was ToughN/A
2021-12-28 22:16 ESTNewsFDA updates EUA for COVID convalescent plasma limiting use to certain patientsN/A
2021-12-09 15:17 ESTNewsADMA Biologics secures new European patent related to S. pneumonia infectionsN/A
2021-11-20 23:16 ESTNewsADMA Biologics: Turning A CornerN/A
2021-11-11 20:31 ESTNewsADMA Biologics raised to Strong Buy at Raymond James citing financial momentumN/A
2021-11-11 00:15 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 01:31 ESTNewsADMA Biologics Q3 2021 Earnings PreviewN/A

About ADMA Biologics, Inc (ADMA):

ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.

See Advanced Chart

General

  • Name ADMA Biologics, Inc
  • Symbol ADMA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 313
  • Fiscal Year EndDecember
  • IPO Date2013-10-17
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.admabiologics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 5.32
  • Price/Book (Most Recent Quarter) 3.7
  • Enterprise Value Revenue 7.55
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.17
  • Profit Margin -166%
  • Operating Margin -138%
  • Return on Assets -21%
  • Return on Equity -124%
  • Revenue 40.3 million
  • Earnings Per Share -$1.24
  • Revenue Per Share $0.53
  • Gross Profit -10155155
  • Quarterly Earnings Growth 42.3%
View More

Highlights

  • Market Capitalization 195.71 million
  • EBITDA -52103768
  • Analyst Target Price $8.83
  • Book Value Per Share $0.80
View More

Share Statistics

  • Shares Outstanding 94.55 million
  • Shares Float 76.07 million
  • % Held by Insiders 213%
  • % Held by Institutions 54.51%
  • Shares Short 8.18 million
  • Shares Short Prior Month 8.75 million
  • Short Ratio 1.91
  • Short % of Float 12%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • Beta 1.7
  • 52 Week High $4.2
  • 52 Week Low $1.73
  • 50 Day Moving Average 2.42
  • 200 Day Moving Average 2.23
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

ADMA Biologics, Inc (ADMA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ADMA Biologics, Inc (ADMA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$N/A-$0.19-$0.204.04%
2020-06-302020-08-05$N/A-$0.23-$0.16-42.24%
2020-03-312020-05-06$N/A-$0.26-$0.11-128.07%
2019-12-312020-03-12$12.04 million-$0.18-$0.18-0.95%
2019-09-302019-11-06$7.22 million-$0.19-$0.2315.56%
2019-06-302019-08-08$6.56 million-$0.25-$0.2914.65%
2019-03-312019-05-08$3.53 million-$0.28-$0.3211.39%
2018-12-312019-03-13$4.06 million-$0.39-$0.33-17.15%
2018-09-302018-11-08$4.23 million-$0.33-$0.31-6.45%
2018-06-302018-08-10$4.66 million-$0.35-$0.31-11.86%
2018-03-312018-05-14$4.04 million-$0.39-$0.31-26.83%
2017-12-312018-03-05$12 million-$0.24-$0.3938.46%
2017-09-302017-11-03$4.73 million-$0.59-$0.50-18.59%
2017-06-302017-08-11$3.4 million-$0.55-$0.30-84.87%
2017-03-312017-05-12$2.63 million-$0.51-$0.28-80.53%
2016-12-312017-02-24$3.33 million-$0.34-$0.32-5.59%
2016-09-302016-11-10$2.94 million-$0.34-$0.4117.87%
2016-06-302016-08-12$2.27 million-$0.50-$0.38-30.89%
2016-03-312016-05-13$2.12 million-$0.43-$0.442.82%
2015-12-312016-03-23$2.51 million-$0.44-$0.452.22%
2015-09-302015-11-10$1.85 million-$0.48-$0.39-23.08%
2015-06-302015-08-11$1.31 million-$0.44-$0.35-25.71%
2015-03-312015-05-12$1.5 million-$0.37-$0.382.63%
2014-12-312015-03-09$1.49 million-$0.38-$0.380%
2014-09-302014-11-10$1.37 million-$0.36-$0.372.7%
2014-06-302014-08-11$1.5 million-$0.43-$0.5217.31%
2014-03-312014-05-12$1.56 million-$0.64-$0.49-30.61%
2013-12-312014-03-28$425000-$0.54-$0.47-14.89%
2013-09-302013-11-12$1.11 million-$0.29

ADMA Biologics, Inc (ADMA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

ADMA Biologics, Inc (ADMA) Chart:

ADMA Biologics, Inc (ADMA) News:

Below you will find a list of latest news for ADMA Biologics, Inc (ADMA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ADMA Biologics, Inc (ADMA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-16318.01CALL0 81181.36TRUE00
2025-05-16514.77CALL0 7724.56TRUE00
2025-05-161010.44CALL0 90250.23TRUE00
2025-05-16118.73CALL0 11377.94TRUE00
2025-05-161210.2CALL4 56276.44TRUE10.20
2025-05-16139.3CALL2 25172.71TRUE9.30
2025-05-16148.3CALL3 104223.7TRUE8.30
2025-05-16157.3CALL4 270122.33TRUE0.50.07
2025-05-16166CALL0 36792.04TRUE00
2025-05-16175.6CALL115 44690.83TRUE0.080.01
2025-05-16184.6CALL4 57076.06TRUE0.40.1
2025-05-16193.8CALL10 131477.56TRUE0.40.12
2025-05-16203.1CALL40 104179.48TRUE0.50.19
2025-05-16212.37CALL29 82274.79TRUE0.370.19
2025-05-16221.8CALL287 585873.85TRUE0.40.29
2025-05-16231.3CALL22 99471.66FALSE0.20.18
2025-05-16240.89CALL16 50669.14FALSE0.040.05
2025-05-16250.59CALL35 156167.47FALSE0.170.4
2025-05-16260.35CALL86 25564.38FALSE0.050.17
2025-05-16270.25CALL6 8066.54FALSE0.030.14
2025-05-16280.1CALL33 3759.58FALSE-0.1-0.5
2025-05-16300.05CALL0 4069.05FALSE00
2025-05-16350.03CALL0 4081.59FALSE00
2025-05-1630.1PUT0 1641.71FALSE00
2025-05-1650.3PUT0 1471.15FALSE00
2025-05-16100.2PUT0 251267.24FALSE00
2025-05-16110.14PUT0 13240.46FALSE00
2025-05-16120.29PUT0 11165.02FALSE00
2025-05-16130.1PUT0 108177.96FALSE00
2025-05-16140.15PUT0 47172.75FALSE00
2025-05-16150.1PUT1 242100.73FALSE0.020.25
2025-05-16160.15PUT1 168195.43FALSE00
2025-05-16170.22PUT0 113390.7FALSE00
2025-05-16180.21PUT1 33085.57FALSE-0.15-0.42
2025-05-16190.5PUT1 47583.09FALSE-0.04-0.07
2025-05-16200.8PUT17 23084.06FALSE-0.05-0.06
2025-05-16211.15PUT61 19075.41FALSE-0.11-0.09
2025-05-16221.51PUT1 15878.22FALSE0.060.04
2025-05-16231.93PUT1 8572.34TRUE0.020.01
2025-05-16244.9PUT0 650.18TRUE00
2025-05-16253.43PUT0 560.16TRUE00
2025-05-16265PUT0 1130.22TRUE00
2025-05-16275.39PUT0 269.08TRUE00
2025-05-16280PUT0 085.64TRUE00
2025-05-16300PUT0 083.37TRUE00
2025-05-16350PUT0 0209.87TRUE00
2025-06-20140CALL0 0167.61TRUE00
2025-06-20156.5CALL0 175.59TRUE00
2025-06-20165.64CALL0 2269.18TRUE00
2025-06-20175.78CALL1 3164.21TRUE0.360.07
2025-06-20184.9CALL2 5460.34TRUE4.90
2025-06-20194.2CALL5 7062.4TRUE0.20.05
2025-06-20203.53CALL47 7862.41TRUE0.330.1
2025-06-20212.82CALL1 5758.87TRUE0.170.06
2025-06-20222.3CALL12 3759.06TRUE0.250.12
2025-06-20231.9CALL11 1160.46FALSE0.10.06
2025-06-20241.37CALL2 4756.08FALSE0.170.14
2025-06-20251.07CALL7 1056.3FALSE-0.03-0.03
2025-06-20260.65CALL0 1756.39FALSE00
2025-06-20270.5CALL1 056.27FALSE0.50
2025-06-20280.45CALL21 055.38FALSE0.450
2025-06-20290CALL0 054.92FALSE00
2025-06-20300.27CALL6 256.75FALSE0.270
2025-06-20140PUT0 075.45FALSE00
2025-06-20150PUT0 076.04FALSE00
2025-06-20160.51PUT0 30162.12FALSE00
2025-06-20170.41PUT600 40368.45FALSE-0.07-0.15
2025-06-20180.6PUT0 1972.87FALSE00
2025-06-20190PUT0 068.34FALSE00
2025-06-20201.1PUT0 1063.41FALSE00
2025-06-20210PUT0 047.8FALSE00
2025-06-20220PUT0 059.58FALSE00
2025-06-20232.95PUT0 1058.21TRUE00
2025-06-20243.79PUT0 157.61TRUE00
2025-06-20254.54PUT0 456.4TRUE00
2025-06-20265.34PUT0 256.31TRUE00
2025-06-20270PUT0 056.11TRUE00
2025-06-20280PUT0 060.3TRUE00
2025-06-20290PUT0 073.98TRUE00
2025-06-20300PUT0 0107.29TRUE00
2025-08-15514.42CALL0 1197.57TRUE00
2025-08-15109.2CALL0 1280.34TRUE00
2025-08-15110CALL0 0114.87TRUE00
2025-08-15128.12CALL0 6177.03TRUE00
2025-08-15135.92CALL0 3691.76TRUE00
2025-08-15147.87CALL0 4471.63TRUE00
2025-08-15157.11CALL0 3769.87TRUE00
2025-08-15167.34CALL0 20670.65TRUE00
2025-08-15176.4CALL0 17168.1TRUE00
2025-08-15184.8CALL0 20867.51TRUE00
2025-08-15194.98CALL105 49865.7TRUE0.150.03
2025-08-15204.37CALL5 21265.27TRUE-0.03-0.01
2025-08-15213.85CALL70 36062.64TRUE0.170.05
2025-08-15223.28CALL211 48462.28TRUE0.260.09
2025-08-15232.8CALL2 366359.88FALSE0.210.08
2025-08-15242.4CALL1 32359.58FALSE0.070.03
2025-08-15252.05CALL125 119759.34FALSE0.250.14
2025-08-15261.55CALL0 5958.2FALSE00
2025-08-15271.3CALL0 1757.76FALSE00
2025-08-15281.1CALL0 2857.04FALSE00
2025-08-15290.46CALL0 156.69FALSE00
2025-08-15300.65CALL0 655.55FALSE00
2025-08-15350.28CALL4 8554.42FALSE0.280
2025-08-1550PUT0 0152.38FALSE00
2025-08-15100.28PUT0 15115.66FALSE00
2025-08-15110.5PUT0 395.41FALSE00
2025-08-15120.26PUT0 6778.16FALSE00
2025-08-15131.04PUT0 8878.17FALSE00
2025-08-15140.58PUT0 6873.69FALSE00
2025-08-15150.5PUT0 8273.15FALSE00
2025-08-15160.75PUT1 8070.22FALSE0.750
2025-08-15170.95PUT9 19268.1FALSE00
2025-08-15181.15PUT0 12665.04FALSE00
2025-08-15192.7PUT0 2565FALSE00
2025-08-15202.5PUT0 7664.27FALSE00
2025-08-15212.75PUT0 4562.99FALSE00
2025-08-15222.65PUT0 3062.79FALSE00
2025-08-15233.35PUT6 1163.07TRUE00
2025-08-15246.8PUT0 159.84TRUE00
2025-08-15255.2PUT0 759.7TRUE00
2025-08-15268.2PUT0 357.58TRUE00
2025-08-15270PUT0 061TRUE00
2025-08-15288.7PUT0 2659.32TRUE00
2025-08-15290PUT0 055.26TRUE00
2025-08-15300PUT0 059.41TRUE00
2025-08-15350PUT0 0100.34TRUE00
2025-11-2150CALL0 0107.85TRUE00
2025-11-21100CALL0 072.37TRUE00
2025-11-21110CALL0 090.53TRUE00
2025-11-21127.27CALL0 877.1TRUE00
2025-11-21138.4CALL0 181.91TRUE00
2025-11-21149.05CALL0 5184.25TRUE00
2025-11-21157.65CALL0 667.73TRUE00
2025-11-21165.5CALL0 4767.13TRUE00
2025-11-21175.2CALL0 166.81TRUE00
2025-11-21186.4CALL0 2263.78TRUE00
2025-11-21195.3CALL0 4763.13TRUE00
2025-11-21205.1CALL0 5462.7TRUE00
2025-11-21214.85CALL6 3160.04TRUE4.850
2025-11-21224.49CALL3 5861.47TRUE0.490.12
2025-11-21232.52CALL0 1064.83FALSE00
2025-11-21243.3CALL0 3059.21FALSE00
2025-11-21252.95CALL0 3059.13FALSE00
2025-11-21262.73CALL5 1956.81FALSE2.730
2025-11-21272.04CALL0 11057.59FALSE00
2025-11-21301.53CALL40 053.08FALSE-0.3-0.16
2025-11-21350.91CALL0 25246.13FALSE00
2025-11-2150PUT0 0160.47FALSE00
2025-11-21100PUT0 088.1FALSE00
2025-11-21110PUT0 074.62FALSE00
2025-11-21120PUT0 073.65FALSE00
2025-11-21130PUT0 071.64FALSE00
2025-11-21141.4PUT0 2668.23FALSE00
2025-11-21151.05PUT0 3567.21FALSE00
2025-11-21161.38PUT0 1965.41FALSE00
2025-11-21171.84PUT0 1466.2FALSE00
2025-11-21181.92PUT12 3164FALSE1.920
2025-11-21193.8PUT0 5963.76FALSE00
2025-11-21204.2PUT0 2463.17FALSE00
2025-11-21213.4PUT0 1561.57FALSE00
2025-11-21224.3PUT0 2061.01FALSE00
2025-11-21234.2PUT0 2559.91TRUE00
2025-11-21245.7PUT0 5461.27TRUE00
2025-11-21257.22PUT0 2162.09TRUE00
2025-11-21267.5PUT0 158.72TRUE00
2025-11-21277.8PUT0 257.09TRUE00
2025-11-21300PUT0 056.32TRUE00
2025-11-21350PUT0 055.72TRUE00
2026-01-16318.9CALL0 2106.17TRUE00
2026-01-16517.51CALL40 8279.28TRUE17.510
2026-01-16811.9CALL0 883.66TRUE00
2026-01-161013.05CALL0 3869.94TRUE00
2026-01-16138CALL0 2665.24TRUE00
2026-01-16158.9CALL5 226062.15TRUE00
2026-01-16177.2CALL0 19360.94TRUE00
2026-01-16205.6CALL2 607056.26TRUE5.60
2026-01-16224.7CALL22 33156.71TRUE0.350.08
2026-01-16253.08CALL0 74259.76FALSE00
2026-01-16272.3CALL0 57448.24FALSE00
2026-01-16301.9CALL51 471851.96FALSE0.030.02
2026-01-16351CALL20 362249.89FALSE00
2026-01-1630PUT0 0186.84FALSE00
2026-01-1650PUT0 0137.55FALSE00
2026-01-1680.45PUT0 1897.06FALSE00
2026-01-16100.45PUT0 371.55FALSE00
2026-01-16130.78PUT0 105064.96FALSE00
2026-01-16151.15PUT15 24762.63FALSE0.050.05
2026-01-16171.7PUT20 17560.42FALSE-0.3-0.15
2026-01-16202.8PUT36 31857.67FALSE0.10.04
2026-01-16223.8PUT10 6957.17FALSE3.80
2026-01-16255.5PUT10 4855.57TRUE5.50
2026-01-16278.5PUT0 5052.58TRUE00
2026-01-16300PUT0 050.67TRUE00
2026-01-16350PUT0 050.27TRUE00
2027-01-15318.54CALL0 8136.71TRUE00
2027-01-15515.36CALL0 693.8TRUE00
2027-01-15812.79CALL0 668.45TRUE00
2027-01-151013.35CALL1 52466.74TRUE13.350
2027-01-151311.5CALL0 562.36TRUE00
2027-01-15159.92CALL0 37061.17TRUE00
2027-01-15179.3CALL0 21669.67TRUE00
2027-01-15208CALL6 35157.2TRUE80
2027-01-15227.08CALL8 29255.9TRUE-0.22-0.03
2027-01-15255.55CALL0 44055.41FALSE00
2027-01-15274.5CALL0 8554.46FALSE00
2027-01-15303.95CALL0 10547.98FALSE00
2027-01-15353CALL0 15251.22FALSE00
2027-01-1530PUT0 0136.4FALSE00
2027-01-1550PUT0 0103.43FALSE00
2027-01-1580.65PUT0 360.19FALSE00
2027-01-15101.83PUT0 155.25FALSE00
2027-01-15132.6PUT0 101962.02FALSE00
2027-01-15152.63PUT0 10361.4FALSE00
2027-01-15173.6PUT0 8759.45FALSE00
2027-01-15206.13PUT0 1458.48FALSE00
2027-01-15225.7PUT90 10058.13FALSE5.70
2027-01-15257.45PUT5 157.04TRUE7.450
2027-01-15270PUT0 054.88TRUE00
2027-01-15300PUT0 055.32TRUE00
2027-01-15350PUT0 054.96TRUE00

Latest ADMA Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST38$1.905
Jun 13, 2022 7:59 PM EST100$1.905
Jun 13, 2022 7:59 PM EST100$1.905
Jun 13, 2022 7:59 PM EST36$1.905
Jun 13, 2022 7:59 PM EST100$1.9

ADMA Biologics, Inc (ADMA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000713/0001193805-20-000713-index.htm
2019-10-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1368514/000000000019014431/0000000000-19-014431-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000083423720008032/0000834237-20-008032-index.htm
2020-03-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000083423720009209/0000834237-20-009209-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924319014466/0000899243-19-014466-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924320003914/0000899243-20-003914-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924320009225/0000899243-20-009225-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000091957419001192/0000919574-19-001192-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000091957420001141/0000919574-20-001141-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000108514619000734/0001085146-19-000734-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000108514620000752/0001085146-20-000752-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000112329219000868/0001123292-19-000868-index.htm
2019-06-07SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1368514/000112329219000869/0001123292-19-000869-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000114036120010160/0001140361-20-010160-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1368514/000114036120010161/0001140361-20-010161-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312519040961/0001193125-19-040961-index.htm
2019-05-23SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312519154707/0001193125-19-154707-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312520038101/0001193125-20-038101-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001175/0001193805-18-001175-index.htm
2018-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001198/0001193805-18-001198-index.htm
2018-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001210/0001193805-18-001210-index.htm
2018-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001238/0001193805-18-001238-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001316/0001193805-18-001316-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380518001319/0001193805-18-001319-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001425/0001193805-18-001425-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001429/0001193805-18-001429-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001431/0001193805-18-001431-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000012/0001193805-19-000012-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000026/0001193805-19-000026-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000090/0001193805-19-000090-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000091/0001193805-19-000091-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000092/0001193805-19-000092-index.htm
2019-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000098/0001193805-19-000098-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000160/0001193805-19-000160-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000246/0001193805-19-000246-index.htm
2019-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000251/0001193805-19-000251-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000254/0001193805-19-000254-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000280/0001193805-19-000280-index.htm
2019-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000281/0001193805-19-000281-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000292/0001193805-19-000292-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000293/0001193805-19-000293-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000294/0001193805-19-000294-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000295/0001193805-19-000295-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000296/0001193805-19-000296-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000297/0001193805-19-000297-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000301/0001193805-19-000301-index.htm
2019-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000332/0001193805-19-000332-index.htm
2019-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000339/0001193805-19-000339-index.htm
2019-04-05PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000346/0001193805-19-000346-index.htm
2019-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000366/0001193805-19-000366-index.htm
2019-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000415/0001193805-19-000415-index.htm
2019-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000441/0001193805-19-000441-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000454/0001193805-19-000454-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000455/0001193805-19-000455-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000470/0001193805-19-000470-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000490/0001193805-19-000490-index.htm
2019-05-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000492/0001193805-19-000492-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000496/0001193805-19-000496-index.htm
2019-05-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000498/0001193805-19-000498-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000521/0001193805-19-000521-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/0001193805-19-000522-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/0001193805-19-000523-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/0001193805-19-000524-index.htm
2019-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000525/0001193805-19-000525-index.htm
2019-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000540/0001193805-19-000540-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000559/0001193805-19-000559-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000561/0001193805-19-000561-index.htm
2019-06-128-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000569/0001193805-19-000569-index.htm
2019-07-01PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000614/0001193805-19-000614-index.htm
2019-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000621/0001193805-19-000621-index.htm
2019-07-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000637/0001193805-19-000637-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000714/0001193805-19-000714-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000715/0001193805-19-000715-index.htm
2019-08-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000761/0001193805-19-000761-index.htm
2019-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000774/0001193805-19-000774-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000798/0001193805-19-000798-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000839/0001193805-19-000839-index.htm
2019-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000887/0001193805-19-000887-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000893/0001193805-19-000893-index.htm
2019-10-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1368514/000119380519000903/0001193805-19-000903-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000905/0001193805-19-000905-index.htm
2019-10-07424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000907/0001193805-19-000907-index.htm
2019-10-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001327/0001193805-19-001327-index.htm
2019-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001351/0001193805-19-001351-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001355/0001193805-19-001355-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001361/0001193805-19-001361-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001396/0001193805-19-001396-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519001398/0001193805-19-001398-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001423/0001193805-19-001423-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001461/0001193805-19-001461-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001941/0001193805-19-001941-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000010/0001193805-20-000010-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000024/0001193805-20-000024-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000033/0001193805-20-000033-index.htm
2020-02-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000106/0001193805-20-000106-index.htm
2020-02-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000109/0001193805-20-000109-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000110/0001193805-20-000110-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000129/0001193805-20-000129-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/0001193805-20-000133-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/0001193805-20-000135-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000138/0001193805-20-000138-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000139/0001193805-20-000139-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000259/0001193805-20-000259-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/0001193805-20-000285-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000286/0001193805-20-000286-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000287/0001193805-20-000287-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/0001193805-20-000288-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/0001193805-20-000289-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000290/0001193805-20-000290-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000291/0001193805-20-000291-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000292/0001193805-20-000292-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000293/0001193805-20-000293-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000300/0001193805-20-000300-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000348/0001193805-20-000348-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000349/0001193805-20-000349-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000377/0001193805-20-000377-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000452/0001193805-20-000452-index.htm
2020-04-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000474/0001193805-20-000474-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000502/0001193805-20-000502-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000529/0001193805-20-000529-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000548/0001193805-20-000548-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000549/0001193805-20-000549-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000550/0001193805-20-000550-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000551/0001193805-20-000551-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000552/0001193805-20-000552-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000553/0001193805-20-000553-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000561/0001193805-20-000561-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000562/0001193805-20-000562-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000618/0001193805-20-000618-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000638/0001193805-20-000638-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000710/0001193805-20-000710-index.htm
2020-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000712/0001193805-20-000712-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000713/0001193805-20-000713-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000770/0001193805-20-000770-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000957/0001193805-20-000957-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000960/0001193805-20-000960-index.htm
2020-08-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000961/0001193805-20-000961-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001004/0001193805-20-001004-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001036/0001193805-20-001036-index.htm
2020-08-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001111/0001193805-20-001111-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001128/0001193805-20-001128-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/0001193805-20-001129-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/0001193805-20-001135-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001139/0001193805-20-001139-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001390/0001193805-20-001390-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520001392/0001193805-20-001392-index.htm
2020-11-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520001393/0001193805-20-001393-index.htm
2019-10-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1368514/999999999519002318/9999999995-19-002318-index.htm
2018-09-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1368514/999999999718008174/9999999997-18-008174-index.htm
2019-04-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1368514/999999999719002962/9999999997-19-002962-index.htm
2020-02-03SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1368514/999999999720000431/9999999997-20-000431-index.htm
2020-02-10SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1368514/999999999720000623/9999999997-20-000623-index.htm

ADMA Biologics, Inc (ADMA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ADMA Biologics, Inc (ADMA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 213%
Institutional Ownership: 5451%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-05-17Jerrold B GrossmanDirectorBuy12,000.004.0048,000.00110,007.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/0001193805-19-000524-index.htm
2019-05-21PERCEPTIVE ADVISORS LLC10% Share HolderBuy4,000,000.004.0016,000,000.0011,521,102.00https://www.sec.gov/Archives/edgar/data/1368514/000089924319014466/0000899243-19-014466-index.htm
2020-02-11Jerrold B GrossmanDirectorBuy22,857.003.5079,999.50132,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2020-02-28Jerrold B GrossmanDirectorBuy7,500.00140,364.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/0001193805-20-000288-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy200.002.87574.00140,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy5,000.002.8914,450.00145,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy5,000.002.9014,475.00150,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-21Jerrold B GrossmanDirectorBuy5,000.002.5612,800.00155,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-08-21Jerrold B GrossmanDirectorBuy300.002.62786.00155,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-02-11PERCEPTIVE ADVISORS LLC10% Share HolderBuy4,563,700.003.5015,972,950.0016,084,802.00https://www.sec.gov/Archives/edgar/data/1368514/000089924320003914/0000899243-20-003914-index.htm
2020-09-10Jerrold B GrossmanDirectorBuy5,000.002.2211,100.00160,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/0001193805-20-001135-index.htm
2020-03-19PERCEPTIVE ADVISORS LLC10% Share HolderBuy500,000.002.101,050,000.0016,584,802.00https://www.sec.gov/Archives/edgar/data/1368514/000089924320009225/0000899243-20-009225-index.htm
2020-02-28Adam S GrossmanPresident and CEOBuy100,000.00166,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000287/0001193805-20-000287-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy10.003.0630.60166,108.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy2,990.003.079,179.30169,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy2,000.003.046,080.00171,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-11Adam S GrossmanPresident and CEOBuy1,000.002.972,970.00172,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-09-08Adam S GrossmanPresident and CEOBuy4,000.002.248,959.60176,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001128/0001193805-20-001128-index.htm
2019-05-17James MondEVP, CSO and CMOBuy4,500.004.0018,000.0017,889.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/0001193805-19-000522-index.htm
2020-08-13MARTHA J DEMSKIDirectorBuy2,000.002.885,760.002,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001036/0001193805-20-001036-index.htm
2020-02-11James MondCSO and CMOBuy4,285.003.5014,997.5022,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/0001193805-20-000133-index.htm
2020-02-11Jerrold B GrossmanDirectorBuy22,857.003.5079,999.5022,857.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2019-05-17BRIAN LENZEVP, CFOBuy5,000.004.0020,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000521/0001193805-19-000521-index.htm
2020-02-11BRIAN LENZEVP, CFOBuy7,142.003.5024,997.0032,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000129/0001193805-20-000129-index.htm
2019-05-17Adam S GrossmanPresident and CEOBuy5,000.004.0020,000.0037,527.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2020-09-11MARTHA J DEMSKIDirectorBuy2,200.002.295,038.004,200.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001139/0001193805-20-001139-index.htm
2019-06-06Biotest Divestiture Trust10% Share HolderSell5,813,954.003.7521,802,327.504,295,580.00https://www.sec.gov/Archives/edgar/data/1368514/000112329219000868/0001123292-19-000868-index.htm
2020-02-28ERIC I RICHMANDirectorBuy7,500.0044,030.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000290/0001193805-20-000290-index.htm
2019-05-17Lawrence P. GuiheenDirectorBuy25,000.004.00100,000.0050,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/0001193805-19-000523-index.htm
2020-02-28James MondEVP, CSO and CMOBuy40,000.0062,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/0001193805-20-000285-index.htm
2020-02-11Adam S GrossmanPresident and CEOBuy28,571.003.5099,998.5066,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm
2020-08-10James MondEVP, CSO and CMOBuy5,000.002.8814,400.0067,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-08-10James MondEVP, CSO and CMOBuy2,000.002.885,750.0069,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-02-11Lawrence P. GuiheenDirectorBuy20,000.003.5070,000.0070,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/0001193805-20-000135-index.htm
2020-02-28BRIAN LENZEVP, CFOBuy40,000.0072,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000286/0001193805-20-000286-index.htm
2020-09-08James MondEVP, CSO and CMOBuy4,000.002.208,800.0073,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/0001193805-20-001129-index.htm
2020-02-28Bryant FongDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000293/0001193805-20-000293-index.htm
2020-02-28DOV A MD GOLDSTEINDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000291/0001193805-20-000291-index.htm
2020-02-28STEVE ELMSDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000292/0001193805-20-000292-index.htm
2020-08-11BRIAN LENZEVP, CFOBuy4,000.002.9711,860.0076,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001004/0001193805-20-001004-index.htm
2020-02-28Lawrence P. GuiheenDirectorBuy7,500.0077,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/0001193805-20-000289-index.htm
2019-05-17Adam S GrossmanPresident and CEOBuy25,000.004.00100,000.00821,301.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2020-02-11Adam S GrossmanPresident and CEOBuy57,143.003.50200,000.50878,444.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm